Medical Decision Making

1981 - 2025

Bibliographic data for series maintained by SAGE Publications ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 33, issue 8, 2013

Estimating the Cost of No-Shows and Evaluating the Effects of Mitigation Strategies pp. 976-985

Bjorn P. Berg, Michael Murr, David Chermak, Jonathan Woodall, Michael Pignone, Robert S. Sandler and Brian T. Denton

Accounting for Costs, QALYs, and Capacity Constraints pp. 986-997

Glenis J. Crane, Steven M. Kymes, Janet E. Hiller, Robert Casson, Adam Martin and Jonathan D. Karnon

Continuous versus Intermittent Data Collection of Health Care Utilization pp. 998-1008

Marike R. C. Hendriks, Maiwenn J. Al, Michel H. C. Bleijlevens, Jolanda C. M. van Haastregt, Harry F. J. M. Crebolder, Jacques Th. M. van Eijk and Silvia M. A. A. Evers

Link between Process and Appraisal in Coverage Decisions pp. 1009-1025

Katharina E. Fischer, Björn Stollenwerk and Wolf H. Rogowski

Vaccination, Herd Behavior, and Herd Immunity pp. 1026-1038

Matan J. Cohen, Mayer Brezis, Colin Block, Adele Diederich and David Chinitz

Applying the Payoff Time Framework to Carotid Artery Disease Management pp. 1039-1050

Theodore H. Yuo, Mark S. Roberts, R. Scott Braithwaite, Chung-Chou H. Chang and Kevin L. Kraemer

Multiple Imputation Methods for Handling Missing Data in Cost-effectiveness Analyses That Use Data from Hierarchical Studies pp. 1051-1063

Manuel Gomes, Karla Díaz-Ordaz, Richard Grieve and Michael G. Kenward

Volume 33, issue 7, 2013

Linear Regression Metamodeling as a Tool to Summarize and Present Simulation Model Results pp. 880-890

Hawre Jalal, Bryan Dowd, François Sainfort and Karen M. Kuntz

Medical Therapy v. PCI in Stable Coronary Artery Disease pp. 891-905

Harindra C. Wijeysundera, George Tomlinson, Dennis T. Ko, Vladimir Dzavik and Murray D. Krahn

Management of Undescended Testis pp. 906-919

M. Elske van den Akker–van Marle, Mascha Kamphuis, Helma B. M. van Gameren–Oosterom, Frank H. Pierik and Job Kievit

Too Much of a Good Thing? When to Stop Catch-Up Vaccination pp. 920-936

David W. Hutton and Margaret L. Brandeau

Nutritional Policy Changes in the Supplemental Nutrition Assistance Program pp. 937-948

Sanjay Basu, Hilary Seligman and Jay Bhattacharya

Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases pp. 949-960

Amanda R. Patrick, Jessica M. Franklin, Milton C. Weinstein, Robert J. Glynn and Sebastian Schneeweiss

The Half-Cycle Correction Revisited pp. 961-970

David M. J. Naimark, Nader N. Kabboul and Murray D. Krahn

Volume 33, issue 6, 2013

Extrapolation of Survival Data in Cost-effectiveness Analyses pp. 740-742

Richard Grieve, Neil Hawkins and Mark Pennington

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data pp. 743-754

Nicholas R. Latimer

An Efficient Method for Computing Single-Parameter Partial Expected Value of Perfect Information pp. 755-766

Mark Strong and Jeremy E. Oakley

A Mathematical Approach for Evaluating Markov Models in Continuous Time without Discrete-Event Simulation pp. 767-779

Joost van Rosmalen, Mehlika Toy and James F. O’Mahony

Development of a Framework for Cohort Simulation in Cost-Effectiveness Analyses Using a Multistep Ordinary Differential Equation Solver Algorithm in R pp. 780-792

Gerardus W. J. Frederix, Johan G. C. van Hasselt, Johan L. Severens, Anke M. Hövels, Alwin D. R. Huitema, Jan A. M. Raaijmakers and Jan H. M. Schellens

US Valuation of the SF-6D pp. 793-803

Benjamin M. Craig, A. Simon Pickard, Elly Stolk and John E. Brazier

Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions pp. 804-818

Nils Gutacker, Chris Bojke, Silvio Daidone, Nancy Devlin and Andrew Street

Patient and Societal Value Functions for the Testing Morbidities Index pp. 819-838

J. Shannon Swan, Chung Yin Kong, Janie M. Lee, Omosalewa Itauma, Elkan F. Halpern, Pablo A. Lee, Sergey Vavinskiy, Olubunmi Williams, Emilie S. Zoltick and Karen Donelan

Common Scale Valuations across Different Preference-Based Measures pp. 839-852

Mónica Hernández Alava, John Brazier, Donna Rowen and Aki Tsuchiya

Expressing Death Risk as Condensed Life Experience and Death Intensity pp. 853-859

John P. A. Ioannidis

Continuously Rethinking the Definition of Influenza for Surveillance Systems pp. 860-868

Farrokh Alemi, Martin J. Atherton, David C. Pattie and Manabu Torii

Sufficiently Important Difference pp. 869-874

Bruce Barrett

Volume 33, issue 5, 2013

Evidence Synthesis for Decision Making 1 pp. 597-606

Sofia Dias, Nicky J. Welton, Alex J. Sutton and A. E. Ades

Evidence Synthesis for Decision Making 2 pp. 607-617

Sofia Dias, Alex J. Sutton, A. E. Ades and Nicky J. Welton

Evidence Synthesis for Decision Making 3 pp. 618-640

Sofia Dias, Alex J. Sutton, Nicky J. Welton and A. E. Ades

Evidence Synthesis for Decision Making 4 pp. 641-656

Sofia Dias, Nicky J. Welton, Alex J. Sutton, Deborah M. Caldwell, Guobing Lu and A. E. Ades

Evidence Synthesis for Decision Making 5 pp. 657-670

Sofia Dias, Nicky J. Welton, Alex J. Sutton and A. E. Ades

Evidence Synthesis for Decision Making 6 pp. 671-678

Sofia Dias, Alex J. Sutton, Nicky J. Welton and A. E. Ades

Bivariate Random-Effects Meta-analysis of Sensitivity and Specificity with the Bayesian SAS PROC MCMC pp. 692-701

Jan Menke

Comparing Bayesian and Frequentist Approaches for Multiple Outcome Mixed Treatment Comparisons pp. 702-714

Hwanhee Hong, Bradley P. Carlin, Tatyana A. Shamliyan, Jean F. Wyman, Rema Ramakrishnan, François Sainfort and Robert L. Kane

Use of Multiparameter Evidence Synthesis to Assess the Appropriateness of Data and Structure in Decision Models pp. 715-730

David Epstein, Leticia García Mochón, Jaime Espín and Marta O. Soares

In Memoriam pp. 731-733

Shikhar Shah, J. Robert Beck and Stephen G. Pauker

Volume 33, issue 4, 2013

The Value of HIV Screening in the United States in the Era of Effective Treatment pp. 457-459

Bruce R. Schackman

Toward a Science of Research Prioritization? The Use of Value of Information by Multidisciplinary Stakeholder Groups pp. 460-462

Rachael L. Fleurence and David O. Meltzer

Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics pp. 463-471

Josh J. Carlson, Rahber Thariani, Josh Roth, Julie Gralow, N. Lynn Henry, Laura Esmail, Pat Deverka, Scott D. Ramsey, Laurence Baker and David L. Veenstra

The Role of Value-of-Information Analysis in a Health Care Research Priority Setting pp. 472-489

Isaac Corro Ramos, Maureen P. M. H. Rutten- van Mölken and Maiwenn J. Al

Evaluation of Markers and Risk Prediction Models pp. 490-501

Ben Van Calster, Andrew J. Vickers, Michael J. Pencina, Stuart G. Baker, Dirk Timmerman and Ewout W. Steyerberg

Rating the Preferences for Potential Harms of Treatments for Cardiovascular Disease pp. 502-509

Guangxiang Zhang, Puja B. Parikh, Soraya Zabihi and David L. Brown

Estimating the Relative Utility of Screening Mammography pp. 510-520

Craig K. Abbey, Miguel P. Eckstein and John M. Boone

Cost-Effectiveness of Adjuvant FOLFOX and 5FU/LV Chemotherapy for Patients with Stage II Colon Cancer pp. 521-532

Mehmet U. S. Ayvaci, Jinghua Shi, Oguzhan Alagoz and Sam J. Lubner

Correlates of Diagnostic Accuracy in Patients with Nonspecific Complaints pp. 533-543

Ralph Hertwig, Nathalie Meier, Christian Nickel, Pia-Cristina Zimmermann, Selina Ackermann, Jan K. Woike and Roland Bingisser

A Note on the Expected Biases in Conventional Iterative Health State Valuation Protocols pp. 544-546

Laura Ternent and Aki Tsuchiya

Predicting the ICECAP-O Capability Index from the WOMAC Osteoarthritis Index pp. 547-557

Paul M. Mitchell, Tracy E. Roberts, Pelham M. Barton, Beth S. Pollard and Joanna Coast

Prediction of Health Preference Values from CD4 Counts in Individuals with HIV pp. 558-566

Pierre K. Isogai, Sergio Rueda, Anita R. Rachlis, Sean B. Rourke and Nicole Mittmann

Scoring the 5-Level EQ-5D pp. 567-578

Eleanor Pullenayegum and Feng Xie

Risk Perception of Prescription Drugs pp. 579-592

Andrea R. Beyer, Barbara Fasolo, Lawrence D. Phillips, Pieter A. de Graeff and Hans L. Hillege

Volume 33, issue 3, 2013

Methods Development for Health Technology Assessment pp. 313-315

Mark Sculpher

Standardization and Regulatory Guidelines May Inhibit Science and Reduce the Usefulness of Analyses Based on the Application of Preference-Based Measures for Policy Decisions pp. 316-319

David Feeny

At the Center of Health Care Policy Making pp. 320-324

Andrew J. Stevens and Carole Longson

Improving the Accuracy and Comparability of Model-Based Economic Evaluations of Health Technologies for Reimbursement Decisions pp. 325-332

Hossein Haji Ali Afzali, Jonathan Karnon and Tracy Merlin

Assessing Personalized Medicines in Australia pp. 333-342

Tracy Merlin, Claude Farah, Camille Schubert, Andrew Mitchell, Janet E. Hiller and Philip Ryan

A Pilot Study Using Machine Learning and Domain Knowledge to Facilitate Comparative Effectiveness Review Updating pp. 343-355

Siddhartha R. Dalal, Paul G. Shekelle, Susanne Hempel, Sydne J. Newberry, Aneesa Motala and Kanaka D. Shetty

The Choice of a Noninformative Prior on Between-Study Variance Strongly Affects Predictions of Future Treatment Effect pp. 356-368

Olga Gajic-Veljanoski, Angela M. Cheung, Ahmed M. Bayoumi and George Tomlinson

The “Hazards†of Extrapolating Survival Curves pp. 369-380

Charlotte Davies, Andrew Briggs, Paula Lorgelly, Göran Garellick and Henrik Malchau

Estimating a Preference-Based Index from the Clinical Outcomes in Routine Evaluation–Outcome Measure (CORE-OM) pp. 381-395

Ifigeneia Mavranezouli, John E. Brazier, Donna Rowen and Michael Barkham

Identifying Individual Changes in Performance With Composite Quality Indicators While Accounting for Regression to the Mean pp. 396-406

Byron J. Gajewski and Nancy Dunton

Multicohort Models in Cost-Effectiveness Analysis pp. 407-414

James F. O’Mahony, Joost van Rosmalen, Ann G. Zauber and Marjolein van Ballegooijen

Methods to Assess Cost-Effectiveness and Value of Further Research When Data Are Sparse pp. 415-436

Marta O. Soares, Jo C. Dumville, Rebecca L. Ashby, Cynthia P. Iglesias, Laura Bojke, Una Adderley, Elizabeth McGinnis, Nikki Stubbs, David J. Torgerson, Karl Claxton and Nicky Cullum

The Impact of Using Informative Priors in a Bayesian Cost-Effectiveness Analysis pp. 437-450

C. Elizabeth McCarron, Eleanor M. Pullenayegum, Lehana Thabane, Ron Goeree and Jean-Eric Tarride

Volume 33, issue 2, 2013

34th Annual Meeting for the Society for Medical Decision Making pp. E1-E137

N/a

Thank You to the Reviewers of 2012 pp. 125-132

N/a

Probability Distributions pp. 133-135

Stephen G. Pauker

An Inquiry About Clinicians’ View of the Distribution of Posttest Probabilities pp. 136-138

Jef Van den Ende, Juan Moreira, Lisine Tuyisenge and Zeno Bisoffi

Author Index For Abstracts pp. E138-E144

N/a

Estimating Health State Utility Values for Joint Health Conditions pp. 139-153

Roberta Ara and Allan J. Wailoo

14th Biennial European Meeting of the Society for Medical Decision Making pp. E145-E203

N/a

A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups pp. 154-162

Nina P. Paynter and Nancy R. Cook

The Utility of Childhood and Adolescent Obesity Assessment in Relation to Adult Health pp. 163-175

Jeremy D. Goldhaber-Fiebert, Rachel E. Rubinfeld, Jay Bhattacharya, Thomas N. Robinson and Paul H. Wise

Derivation of Background Mortality by Smoking and Obesity in Cancer Simulation Models pp. 176-197

Y. Claire Wang, Barry I. Graubard, Marjorie A. Rosenberg, Karen M. Kuntz, Ann G. Zauber, Lisa Kahle, Clyde B. Schechter and Eric J. Feuer

Comparison of Surveillance Strategies for Low-Risk Bladder Cancer Patients pp. 198-214

Yuan Zhang, Brian T. Denton and Matthew E. Nielsen

Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes pp. 215-224

Shital Kamble, Kevin P. Weinfurt, Kevin A. Schulman and Shelby D. Reed

Are Standard Diagnostic Test Characteristics Sufficient for the Assessment of Continual Patient Monitoring? pp. 225-234

Liangyou Chen, Andrew T. Reisner, Xiaoxiao Chen, Andrei Gribok and Jaques Reifman

Evidence of Spillover of Illness among Household Members pp. 235-243

Eve Wittenberg, Grant A. Ritter and Lisa A. Prosser

Generalized Additive Models for the Analysis of EQ-5D Utility Data pp. 244-251

Eleanor M. Pullenayegum, Hoi Suen Wong and Aaron Childs

Testing for Differential Item Functioning within the EQ-5D pp. 252-260

David K. Whynes, Nikola Sprigg, James Selby, Eivind Berge and Philip M. Bath

The Impact of Patients’ Subjective Life Expectancy on Time Tradeoff Valuations pp. 261-270

Emelie Heintz, Marieke Krol and Lars-Ã…ke Levin

“Don’t Know†Responses to Risk Perception Measures pp. 271-281

Erika A. Waters, Jennifer L. Hay, Heather Orom, Marc T. Kiviniemi and Bettina F. Drake

Use of Natural Health Products pp. 282-297

Heather Boon, Natasha Kachan and Andreas Boecker

Identification of a Multistate Continuous-Time Nonhomogeneous Markov Chain Model for Patients with Decreased Renal Function pp. 298-306

Alexander Begun, Andrea Icks, Regina Waldeyer, Sandra Landwehr, Michael Koch and Guido Giani

Corrigendum pp. 307-307

N/a

Volume 33, issue 1, 2013

All Stories Are Not Alike pp. 4-13

Victoria A. Shaffer and Brian J. Zikmund-Fisher

Effect of Narrative Reports about Vaccine Adverse Events and Bias-Awareness Disclaimers on Vaccine Decisions pp. 14-25

Cornelia Betsch, Frank Renkewitz and Niels Haase

Patients’ Experiences of Shared Decision Making in Primary Care Practices in the United Kingdom pp. 26-36

Catherine Fullwood, Anne Kennedy, Anne Rogers, Martin Eden, Caroline Gardner, Joanne Protheroe and David Reeves

When Decisions Should Be Shared pp. 37-47

Meike Müller-Engelmann, Norbert Donner-Banzhoff, Heidi Keller, Lydia Rosinger, Carsten Sauer, Kerstin Rehfeldt and Tanja Krones

Using Comparison Scenarios to Improve Prenatal Risk Communication pp. 48-58

Stefania Pighin, Lucia Savadori, Elisa Barilli, Rino Rumiati, Sara Bonalumi, Maurizio Ferrari and Laura Cremonesi

Patients’ Preferences and Priorities Regarding Colorectal Cancer Screening pp. 59-70

James G. Dolan, Emily Boohaker, Jeroan Allison and Thomas F. Imperiale

On Averages and Peaks pp. 71-77

Shoshana Shiloh, Christopher H. Wade, J. Scott Roberts, Sharon Hensley Alford and Barbara B. Biesecker

Interpreting Patient Decisional Conflict Scores pp. 78-84

Anouk M. Knops, Astrid Goossens, Dirk T. Ubbink, Dink A. Legemate, Lukas J. Stalpers and Patrick M. Bossuyt

Incorporating Patient Decision Aids into Standard Clinical Practice in an Integrated Delivery System pp. 85-97

Clarissa Hsu, David T. Liss, Emily O. Westbrook and David Arterburn

How to Discriminate between Computer-Aided and Computer-Hindered Decisions pp. 98-107

Andrey A. Povyakalo, Eugenio Alberdi, Lorenzo Strigini and Peter Ayton

Why Do Patients Derogate Physicians Who Use a Computer-Based Diagnostic Support System? pp. 108-118

Victoria A. Shaffer, C. Adam Probst, Edgar C. Merkle, Hal Arkes and Mitchell A. Medow